Russia is preparing to deliver in hospitals of the country the first batch of “Avifauna” — domestic medicine for coronavirus COVID-19. The world’s first drug approved for the treatment of coronavirus. About 20 thousand packages already produced, volume of production increases. In clinical trials the drug has reduced the treatment of patients more than doubled.
“Aviewer” developed on the basis of the drug for the treatment of severe influenza, which was used in Japan from 2014. New side effects Russian medications are not found, the TV channel “Russia 24”. It proved its safety, and its efficiency exceeded 80 percent.
“of Course, this is an important breakthrough, — said General Director, Chairman of the Board of RDIF, Kirill Dmitriev. Because Russia was included in a small number of powers that produce drugs against the coronavirus. It is, accordingly, Russia, USA, China and Japan. And we really showed that he was able in a short time to produce the drug, which has very high efficiency. We see that the timing of the virus from the human body, taking the drug are reduced from nine to four days compared with standard therapy. It is definitely good for the clinics. Definitely good that people will get better faster. And, accordingly, after application of this drug is already on the fifth day people cease to be infectious to others, that also reduces the period of more than two times. So, of course, this is an important event not only for Russia but for the global fight against coronavirus”.
